Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panel
Open Access
- 1 April 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 29 (2), 369-375
- https://doi.org/10.1093/ije/29.2.369
Abstract
Background This study aimed to evaluate purified protein derivative (PPD) reactivity and its interrelationship with anergy panel and CD4+ lymphocytes in HIV-infected subjects as compared to PPD reactivity in HIV-uninfected individuals in a tuberculosis endemic and high Bacillus Calmette-Guérin (BCG) coverage environment. Methods Clients of four Mexico City HIV detection centres were screened for HIV-1 antibodies (ELISA or haemagglutination, Western Blot); reactivity to PPD (Mantoux PPD, 5TU RT-23), Candida (1:1000, 0.1 ml), and tetanus toxoid (10Lf, 0.1 ml); and CD4+ T cells. Active tuberculosis was excluded. Informed consent was obtained. Results From 5130 clients 1168 subjects were enrolled; of these 801 (68.6%) were HIV positive. Reactivity to PPD among HIV-positive subjects was found in 174 (22%), 261 (32.6%), and 296 (37%), at PPD cutoff levels of ≥10 mm, ≥5 mm, and ≥2 mm as compared to 224 (61%) of 367 HIV-negative individuals’ reactors to PPD (≥10 mm) (P < 0.001). After exclusion of anergic individuals using two cutoff levels for cutaneous allergens (≤2 mm and ≤5 mm), PPD reactivity between HIV-infected and uninfected individuals continued to be significantly different. Only HIV-infected individuals with CD4+ T cells ≥500 cells/mm3 had similar reactivity to PPD as HIV-uninfected individuals. Variables associated with PPD reactivity were CD4+ T cell counts, BCG scar, HIV infection and age. Conclusions PPD reactivity was useful to diagnose tuberculosis infection only among HIV-infected individuals with CD4+ counts ≥500 cells/mm3. Among individuals with lower counts, lowering cutoff levels or using anergy panel did not permit comparable reactivity as that observed among HIV-uninfected individuals.Keywords
This publication has 12 references indexed in Scilit:
- Guidelines for conducting tuberculin skin test surveys in high prevalence countriesTubercle and Lung Disease, 1996
- Tuberculin reactivity in Bacillus Calmette-Guérin vaccinated subjectsTubercle and Lung Disease, 1996
- Mycobacterial Infection in Mexican AIDS PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Tuberculosis preventive therapy in HIV-infected individuals: A joint statement of the international union against tuberculosis and lung disease (IUATLD) and the global programme on AIDS and the tuberculosis programme of the World Health Organization (WHO)Tubercle and Lung Disease, 1994
- Tuberculin and Anergy Testing in HIV-Seropositive and HIV-Seronegative PersonsAnnals of Internal Medicine, 1993
- Tuberculin Skin Test Reactivity among Adults Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1992
- The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in MexicoAIDS, 1992
- Tuberculin skin testing and the HIV epidemicPublished by American Medical Association (AMA) ,1992
- Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug usersPublished by American Medical Association (AMA) ,1992
- Anergy in Active Pulmonary TuberculosisChest, 1980